Zepto, the fast-growing quick-commerce startup, just announced an exciting new service: Zepto Pharmacy. The company promises medicines delivered in just 10 minutes, and this service is already live in select parts of Mumbai, Bengaluru, Delhi NCR, and Hyderabad.
Aadit Palicha, Zepto’s co-founder and CEO, shared that the team has spent over a year refining every detail—from the customer experience to supply chain logistics and regulatory compliance. Their goal now is to grow steadily, focusing on service quality rather than rushing into scale, since the pharmaceutical category is complex and demands extra care.
Right now, Zepto Pharmacy offers around 1,000 popular products and plans to add over 10,000 SKUs soon. This launch is great news for millions of people who want quick, easy access to medicines—especially in emergencies or just when time is tight. With this move, Zepto is stepping into a space crowded with big players like Tata 1mg, PharmEasy, and Apollo 24|7, which means healthy competition that’s likely to benefit consumers.
Blinkit Expands Into Healthcare Services
Blinkit, owned by Zomato, is also making interesting moves in health and rapid delivery. Recently, they introduced a 10-minute ambulance service in parts of Gurugram—a bold expansion beyond quick commerce groceries. This new offering shows how quick delivery companies are not just racing in groceries or medicines anymore but branching out to essential healthcare services. The competition between Zepto and Blinkit is heating up, pushing innovation and convenience to new levels for customers.
Competitive Landscape and Market Potential
The online pharmacy space in India is booming. The sector is expected to grow at an annual rate of about 16.65% between 2025 and 2033, reaching a market size of around $12.7 billion. Big names like Tata 1mg, PharmEasy, Apollo 24|7, and new startups such as Farmako are constantly refining their offerings—whether it’s quick medicine delivery, online doctor consultations, or health test bookings.
Zepto’s promise of 10-minute deliveries, powered by a dense network of local dark stores, definitely stands out. But the team knows this sector involves regulatory hurdles and operational challenges, so they’re being deliberate about growing without compromising on quality. It’s a wise approach in a field where trust and safety are key.
Zepto’s Financial Growth and Future Prospects
Financially, Zepto is shining. The company saw its revenues jump by 150% in FY25, raking in roughly ₹11,110 crore (about $1.3 billion). At the same time, it managed to cut losses by about half compared to the previous year. Zepto is gearing up for an IPO, expected sometime between late 2025 and early 2026, aiming to increase Indian ownership and create more value with the help of big-name investors.
More than just pharmacy delivery, Zepto plans to keep growing its core quick-commerce categories, and possibly add others like beauty and pet care. This makes it a one-stop rapid delivery platform for urban consumers.
Transforming India’s Digital Health and Retail Ecosystem
Zepto’s pharmacy launch is part of a bigger change happening in India’s digital health and retail space. As chronic diseases rise and people become more aware of fake or substandard medicines, fast and reliable access to genuine medicines is more important than ever. Along with online doctor consultations and lab test services, speedy medicine delivery helps millions get the care they need without waiting.
Blinkit’s new ambulance service shows how fast delivery firms are thinking bigger than just groceries or medicines. Together, these moves paint a picture of an evolving ecosystem where convenience, technology, and healthcare are merging in exciting ways.
With Zepto, Blinkit, and others pushing the envelope, Indian consumers can look forward to better, faster, and more reliable digital health services in the near future.
